• Profile
Close

Sugammadex vs neostigmine for reversal of neuromuscular blockade and postoperative pulmonary complications (STRONGER): A multicenter matched cohort analysis

Anesthesiology May 15, 2020

Kheterpal S, Vaughn MT, Dubovoy TZ, et al. - Given that the occurrence of a major pulmonary complication is seen in 5% of adult patients undergoing noncardiac inpatient surgery, researchers investigated whether the choice of neuromuscular blockade reversal (neostigmine vs sugammadex) is related to a lower incidence of major pulmonary complications. They performed a multicenter observational matched-cohort analysis of surgical cases, in which, 12 US Multicenter Perioperative Outcomes Group hospitals participated. Participants were adults undergoing elective inpatient noncardiac surgical procedures, who received general anesthesia and endotracheal intubation as well as a nondepolarizing neuromuscular blockade agent and reversal. Findings revealed a clinically and statistically significant lower incidence of major pulmonary complications in relation to sugammadex use in a generalizable cohort comprising adult patients undergoing inpatient surgery at US hospitals.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay